These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35697689)

  • 1. Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility.
    Endo Y; Groom L; Celik A; Kraeva N; Lee CS; Jung SY; Gardner L; Shaw MA; Hamilton SL; Hopkins PM; Dirksen RT; Riazi S; Dowling JJ
    Nat Commun; 2022 Jun; 13(1):3403. PubMed ID: 35697689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
    Fiszer D; Shaw MA; Fisher NA; Carr IM; Gupta PK; Watkins EJ; Roiz de Sa D; Kim JH; Hopkins PM
    Anesthesiology; 2015 May; 122(5):1033-46. PubMed ID: 25658027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.
    Lopez JR; Kaura V; Diggle CP; Hopkins PM; Allen PD
    Br J Anaesth; 2018 Oct; 121(4):953-961. PubMed ID: 30236258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the genetic susceptibility to exertional heat illness.
    Gardner L; Miller DM; Daly C; Gupta PK; House C; Roiz de Sa D; Shaw MA; Hopkins PM
    J Med Genet; 2020 Aug; 57(8):531-541. PubMed ID: 32054689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
    Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C
    PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.
    Michelucci A; Paolini C; Boncompagni S; Canato M; Reggiani C; Protasi F
    FASEB J; 2017 Aug; 31(8):3649-3662. PubMed ID: 28465322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a link between malignant hyperthermia and exertional heat illness?
    Muldoon S; Deuster P; Brandom B; Bunger R
    Exerc Sport Sci Rev; 2004 Oct; 32(4):174-9. PubMed ID: 15604937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
    Steinfath M; Singh S; Scholz J; Becker K; Lenzen C; Wappler F; Köchling A; Roewer N; Schulte am Esch J
    J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collapse from exertional heat illness: implications and subsequent decisions.
    Porter AM
    Mil Med; 2003 Jan; 168(1):76-81. PubMed ID: 12546251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
    Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
    FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
    Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
    Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
    Kaufmann A; Kraft B; Michalek-Sauberer A; Weindlmayr M; Kress HG; Steinboeck F; Weigl LG
    Anesth Analg; 2012 May; 114(5):1017-25. PubMed ID: 22415532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
    Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
    Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
    Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenon does not induce contracture in human malignant hyperthermia muscle.
    Baur CP; Klingler W; Jurkat-Rott K; Froeba G; Schoch E; Marx T; Georgieff M; Lehmann-Horn F
    Br J Anaesth; 2000 Nov; 85(5):712-6. PubMed ID: 11094586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
    Yang T; Ta TA; Pessah IN; Allen PD
    J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.